VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd.

May 15, 2008 18:17 ET

VentriPoint Issues Shares to Directors and Consultants as Payment for Services

SEATTLE, WASHINGTON--(Marketwire - May 15, 2008) -


VentriPoint Diagnostics Ltd. ("VentriPoint") (TSX VENTURE:VPT) announces that, pending regulatory approval, it has issued, in aggregate, 240,000 common shares in the capital of VentriPoint (the "Common Shares") to non-officer directors of VentriPoint as payment of services from September 2007 to April 2008. VentriPoint has also issued, in aggregate, 115,271 Common Shares to two consultants for services rendered from February 1, 2008 to April 30, 2008. The Common Shares will be issued at a deemed price of $0.20 per share. The issuance of the Common Shares as payment for services to the directors and consultants was referenced in Note 19 of the December 31, 2007 audited financial statements of VentriPoint dated April 29, 2008.

About VentriPoint Diagnostics

VentriPoint creates diagnostic tools to monitor patients with heart disease - the number one cause of death in developed countries. By using images produced from existing medical imaging systems, the VentriPoint Diagnostic System generates critical heart measurements in a rapid and inexpensive manner not currently available. This breakthrough diagnostic tool is based upon technology received by VentriPoint through its technology license with the University of Washington. The VentriPoint Diagnostic System, together with its associated online service, is being developed for a variety of heart related disease states, including congenital heart disease.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • VentriPoint Diagnostics Ltd.
    Edward Garth
    Chief Financial Officer
    (206) 283-0221
    (206) 283-2309 (FAX)